Akeso

News & Events

Press Releases

In The Media

1. Why is Summit stock in selloff after late-stage trial data for lead asset?

   SeekingAlpha MAY 30, 2025 2:47 PM EDT
   2025-05-30 14:47:46 ET More on Summit Therapeutics Summit Therapeutics: Critical NS...
   READ ARTICLE

2. Summit gains as late-stage trial for lung cancer therapy hits main goal

   SeekingAlpha MAY 30, 2025 7:32 AM EDT
   2025-05-30 08:38:01 ET More on Summit Therapeutics, Akeso Summit Therapeutics Inc. ...
   READ ARTICLE

3. Biotech Outperformance - Can't Take What's Already Earned

   SeekingAlpha MAY 9, 2025 5:37 AM EDT
   2025-05-09 05:37:08 ET Summary The Biotech industry has underperformed due to Trump a...
   READ ARTICLE

4. BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit

   SeekingAlpha MAY 8, 2025 9:24 AM EDT
   2025-05-08 09:24:42 ET Summary BeiGene, Ltd., soon to be BeOne Medicines, is a global...
   READ ARTICLE

5. Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus

   SeekingAlpha APR 27, 2025 2:10 PM EDT
   2025-04-27 14:10:09 ET More on Health Care Sector SPDR Fund ETF XLV Vs. VHT: I Pref...
   READ ARTICLE

6. Summit Therapeutics: New Ivonescimab Data Raise Concerns

   SeekingAlpha APR 26, 2025 9:30 AM EDT
   2025-04-26 09:30:00 ET Summary Summit Therapeutics' share price plunged 36% after Ake...
   READ ARTICLE

7. Merck gains after latest survival data for Summit's cancer drug

   SeekingAlpha APR 25, 2025 3:25 PM EDT
   2025-04-25 15:25:17 ET More on Akeso, Merck, etc. Merck & Co., Inc. 2025 Q1 - R...
   READ ARTICLE

8. Summit plunges 35%; partner Akesso wins FDA nod for cancer drug

   SeekingAlpha APR 25, 2025 12:30 PM EDT
   2025-04-25 12:30:02 ET More on Akeso, Summit Therapeutics, etc. Bullish On Akeso's ...
   READ ARTICLE

9. Summit extends gains as cancer drug outperforms BeiGene's Tevimbra

   SeekingAlpha APR 24, 2025 2:22 PM EDT
   2025-04-24 14:22:16 ET More on Akeso, BeiGene, etc. Bullish On Akeso's Ivonescimab,...
   READ ARTICLE

10. Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain

    SeekingAlpha APR 20, 2025 10:15 AM EDT
    2025-04-20 10:15:00 ET Summary AKESF basically develops antibody technologies. Its ma...
    READ ARTICLE